Open access · OA
via Europe PMC
Metformin for Longevity and Sarcopenia: A Therapeutic Paradox in Aging
Biomedicines · 2026
Abstract
Explores metformin's dual effects on aging, analyzing its potential for longevity alongside the paradoxical risk of worsening sarcopenia.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
S, H., M, Y., & J., W. (2026). Metformin for Longevity and Sarcopenia: A Therapeutic Paradox in Aging. <em>Biomedicines</em>. https://europepmc.org/article/PMC/PMC12938515
Vancouver
S H, M Y, J. W. Metformin for Longevity and Sarcopenia: A Therapeutic Paradox in Aging. Biomedicines. 2026.
BibTeX
@article{han2026Metfor,
title = {Metformin for Longevity and Sarcopenia: A Therapeutic Paradox in Aging},
author = {Han S and Yadav M and Wang J.},
journal = {Biomedicines},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Zeitschrift für Gerontologie und Geriatrie 1999
Citation only
Sarcopenia, hypermetabolism, and aging
Elsevier eBooks 2016
Citation only
The Aging Muscle and Sarcopenia
Elsevier eBooks 2019
Citation only
Aging Muscle and Sarcopenia
Clinics in Geriatric Medicine 2013
Preprint · OA
Normal Cognitive Aging
Journal of Geriatric Oncology 2018
Preprint · OA
Sarcopenia & aging in cancer
Elsevier eBooks 2024
Citation only